Version Française
OK
Logo retour accueil

Last news

  • Collaboration with the French Intergroup of Thoracic Oncology (IFCT)

    IntegraGen is collaborating with the French Intergroup of Thoracic Oncology (IFCT) to explore the role of its proprietary miR-31-3p biomarker in advanced stage non-small cell lung cancer (NSCLC).

    Read more

  • Interpretation of Clinical Exome (ICE) Project

    Integragen, Gustave Roussy, INSERM and Sogeti High Tech announce the launch of the Interpretation of Clinical Exome (ICE) Project.

    Read more

Home

IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests for autism and oncology based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on it's technological expertise and scientific know how.



Autism Oncology Services
Disclaimers - Mentions légales - Crédits